SCHEMBL19401359

SCHEMBL19401359

C/C=C\[C@@H]1CCC[C@H](OC)C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.32
DPP7 Q9UHL4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24435063 1.00 DPP4 (0.32) DPP4DPP7
SCHEMBL5678624 0.83 DPP4 (0.33) DPP4DPP7
SCHEMBL910644 0.77 DPP4 (0.36) DPP4DPP7
SCHEMBL21961848 0.77 DPP4 (0.33) DPP4DPP7
SCHEMBL28244513 0.77 DPP4 (0.33) DPP4DPP7
SCHEMBL1681038 0.74
SCHEMBL14270060 0.74 DPP4 (0.40) DPP4DPP7
SCHEMBL1681034 0.74
SCHEMBL5482843 0.74 DPP4 (0.40) DPP4DPP7
SCHEMBL5682449 0.73 DPP4 (0.31) DPP4DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3433259-B1 CONJUGATES OF TACROLIMUS, THEIR COMPOSITIONS, AND THEIR USES THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2021-06-30 EP disclosed
US-20190194227-A1 BMP POTENTIATORS NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. 2019-06-27 US disclosed
WO-2017165607-A1 CONJUGATES OF TACROLIMUS, THEIR COMPOSITIONS, AND THEIR USES THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2017-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194227-A1 BMP POTENTIATORS BMP1, BMP2, BMP4 DPP4 2292/4885DPP7 1598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.